Alex Martin ’89 is a Biotech CEO, on a mission to cure a rare disease, grew team to 50 people, with $350mm raised

Alex Martin ’89 is a biotech CEO, on a mission to cure a rare disease, we talked about:- building a biotech company, building the team (20 to 50 people!), fundraising (over $350 million!)- executive coaching, being a good sounding board, remove obstacles faced by team members- career path, from a government major at Cornell to a biotech CEO, 1st job, MBA, and more!